ResMed Aktie
175,00
EUR
+1,15
EUR
+0,66
%
204,10
USD
+2,20
USD
+1,09
%
Werbung
ResMed Aktie Analyse
| 25.09.17 | ResMed Underweight | Barclays Capital | |
| 07.04.16 | ResMed Underweight | Barclays Capital | |
| 27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung